gut.bmj18h
PTU-211 Patient preparation prior to gastroscopy: a UK wide survey
Introduction Background: Optimal patient preparation for colonoscopy is shown to improve polyp detection in the colon. In Japan, it is widely accepted practice to administer a mucolytic agent prior to ...
gut.bmj1d
Characterisation of oxidative injury to an intestinal cell line (HT-29) by hydrogen peroxide.
Department of Medicine, Hope Hospital, University of Manchester. Reactive oxygen metabolites have been implicated in causing epithelial cell injury in colonic inflammation. A model of oxidant injury ...
gut.bmj1d
Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs
Dr M J A P Govers, Numico Research BV, PO Box 7005, 6700 CA Wageningen, The Netherlands. BACKGROUND Recent studies suggest that resistant starch (effective in producing butyrate and lowering possibly ...
gut.bmj1d
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.
BACKGROUND: 6-Mercaptopurine and its prodrug azathioprine are effective medications for refractory inflammatory bowel disease. However, use of these drugs has been limited by concerns about their ...
gut.bmj1d
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis
BACKGROUND Butyrate oxidation within the colonocyte is selectively inhibited by hydrogen sulphide, reproducing the metabolic lesion observed in active ulcerative colitis. AIMS To study generation of ...
gut.bmj1d
Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?
Correspondence to Professor Peter Gibson, Department of Gastroenterology, Alfred Hospital, 99 Commercial Road, Melbourne Victoria 3004, Australia; peter.gibson{at}monash.edu IBS is one of the most ...
gut.bmj2d
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
4 Department of Hepatogastroenterology, Hopital Claude Huriez, CHRU Lille, France Correspondence to: Professor J-F Colombel Department of Hepato-Gastroenterology, Hopital Claude Huriez, CHRU de Lille, ...
gut.bmj2d
What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj2d
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
1 Department of Immunology, Pole of Biology, Hôpital Archet 1, CHU de Nice, Université de Nice Sophia-Antipolis, Nice, France 2 EA 6203, Université de Nice Sophia Antipolis Nice, Nice, France 3 ...
gut.bmj2d
Epidemiology of gastro-oesophageal reflux disease: a systematic review
Correspondence to: Professor J Dent Department of Gastroenterology, Hepatology, and General Medicine, Level 7, North Wing, North Terrace, Royal Adelaide Hospital, Adelaide, South Australia 5000, ...
gut.bmj3d
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
Background: Prophylactic efficacy against colitis following lactobacillus consumption in interleukin 10 (IL-10) knockout (KO) mice has been reported. Whether this applies equally to other probiotic ...
gut.bmj3d
O43 The phenotype and TCR repertoire of intestinal CD8+ T cells is altered in coeliac disease
Introduction Coeliac disease (CD) is a common immune-mediated condition driven by aberrant adaptive CD4+ T cell responses to gluten. The cytotoxic CD8+ and γδ+ T cell response in the epithelium is ...